INS and metabolic dysfunction-associated steatotic liver disease: Individuals with NAFLD, who had an increase in the erythrocyte DHA enrichment of ≥2% with the treatment of ω-3 FA, showed positive changes in hepatic insulin sensitivity and hepatic lipid metabolism.